Department of Internal Medicine I, Friedrich Schiller University, Jena, Germany.
Expert Rev Med Devices. 2013 Mar;10(2):247-56. doi: 10.1586/erd.13.1.
Resistant hypertension remains a challenging issue even for modern medicine. Therefore, research is focusing on the development of new technologies to optimize the treatment of this condition. It has been demonstrated that the dysfunction of the sympathetic nervous system is crucial in the development and maintenance of advanced stages of hypertension. Based on these findings, clinical trials have recently shown that catheter-based percutaneous renal denervation therapy is safe and effective in the treatment of resistant hypertension. This review discusses the current scientific knowledge of renal denervation therapy in resistant hypertension, including the different methods that have been described in the literature so far, as well as limitations of the available data. Furthermore, new potential targets for this fascinating therapy will be addressed.
即使对于现代医学来说,耐药性高血压仍然是一个具有挑战性的问题。因此,研究的重点是开发新技术,以优化这种疾病的治疗。已经证明,交感神经系统的功能障碍在高血压的发展和维持中至关重要。基于这些发现,最近的临床试验表明,基于导管的经皮肾去神经治疗在耐药性高血压的治疗中是安全有效的。这篇综述讨论了耐药性高血压中肾去神经治疗的当前科学知识,包括迄今为止文献中描述的不同方法,以及现有数据的局限性。此外,还将探讨这种引人入胜的治疗方法的新潜在靶点。